Concurrent Exercise in Combination With Music Listening in Female Breast Cancer Survivors
Launched by ANA TRIGUEROS MURILLO · Jun 23, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding music therapy to a physical exercise program can help improve the self-esteem, body image, physical strength, fatigue levels, heart and lung fitness, overall quality of life, and sleep quality of women who have survived breast cancer. The exercise program includes both aerobic activities (like walking or cycling) and strength training. Researchers want to see if combining exercise with music is more beneficial than exercise alone for these important aspects of health and well-being.
Women between the ages of 18 and 75 who have been diagnosed with stage 0 to III breast cancer and have finished their main cancer treatments at least six months ago may be eligible to join. The study is only for women who are currently in the survivorship phase and do not have certain health issues, like lymphedema (swelling caused by surgery), hearing problems that would make listening to music difficult, neurological conditions, or other medical reasons that would prevent safe exercise. If you participate, you will be randomly placed in one of two groups: one group will do the exercise program while listening to music, and the other group will do the same exercises without music. Your progress will be checked before starting, right after finishing the program, and again six months later. This study is not yet open for participants but aims to find new ways to support breast cancer survivors in feeling better physically and emotionally.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged between 18 and 75 years with a prior diagnosis of stage 0-III breast cancer.
- • Women currently in the survivorship phase of the disease, regardless of the type of medical or surgical treatment received.
- • A minimum of six months must have elapsed since the completion of primary treatment.
- Exclusion Criteria:
- • History of lymphedema secondary to axillary surgery.
- • Inability to provide informed consent for participation in the study.
- • Prior diagnosis of hearing impairments that hinder or prevent music listening, such as partial or total deafness.
- • Prior diagnosis of any central or peripheral neurological condition.
- • Presence of comorbidities or conditions that contraindicate participation in a physical exercise program.
- • A preliminary screening of participants will be conducted based on the recommendations of the National Comprehensive Cancer Network (NCCN), considering the risk of potential exercise-induced adverse effects.
About Ana Trigueros Murillo
Ana Trigueros Murillo is a clinical trial sponsor dedicated to advancing medical research through the development and oversight of innovative clinical studies. With a commitment to scientific rigor and patient safety, Ana Trigueros Murillo facilitates the efficient execution of trials aimed at improving healthcare outcomes and contributing valuable data to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported